Public Interest Registry Announces 2025 .ORG Impact Awards Finalists, Artist & Actor Common to Host
35 innovative, mission-driven organizations and changemakers selected from nearly 3,000 applicants across…
Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
Anteris Announces Results for the Second Quarter of 2025
MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies…
JBO Vietnam Announces Exclusive 2026 FIFA World Cup Bonuses – Up to 16.8M VND
HANOI, Vietnam, Aug. 11, 2025 /PRNewswire/ -- With excitement growing for the 2026…
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjgrens disease
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are…
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium…
Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants
MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or…
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2025 17:00 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Intermap Announces Date for Second Quarter Earnings
Company will announce second quarter 2025 financial results and host a conference…
Longeveron Announces Up To $17.5 Million Public Offering
MIAMI, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron”…
